A detailed history of Jefferies Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jefferies Group LLC holds 38,341 shares of AZN stock, worth $2.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,341
Previous 46,846 18.16%
Holding current value
$2.54 Million
Previous $3.1 Million 32.08%
% of portfolio
0.02%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$53.02 - $135.75 $450,935 - $1.15 Million
-8,505 Reduced 18.16%
38,341 $2.1 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $450,935 - $1.15 Million
-8,505 Reduced 18.16%
38,341 $2.1 Million
Q2 2022

Sep 21, 2023

BUY
$59.26 - $71.14 $418,197 - $502,034
7,057 Added 17.74%
46,846 $3.1 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $418,197 - $502,034
7,057 Added 17.74%
46,846 $3.1 Million
Q1 2022

Sep 21, 2023

SELL
$55.72 - $67.12 $476,573 - $574,077
-8,553 Reduced 17.69%
39,789 $2.64 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $476,573 - $574,077
-8,553 Reduced 17.69%
39,789 $2.64 Million
Q4 2021

Sep 21, 2023

SELL
$54.02 - $63.83 $1.5 Million - $1.78 Million
-27,844 Reduced 36.55%
48,342 $2.82 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $1.5 Million - $1.78 Million
-27,844 Reduced 36.55%
48,342 $2.82 Million
Q3 2021

Sep 21, 2023

BUY
$55.56 - $60.79 $2.17 Million - $2.38 Million
39,135 Added 105.62%
76,186 $4.58 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $2.17 Million - $2.38 Million
39,135 Added 105.62%
76,186 $4.58 Million
Q1 2021

Sep 21, 2023

SELL
$47.16 - $54.44 $945,699 - $1.09 Million
-20,053 Reduced 35.12%
37,051 $1.84 Million
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $945,699 - $1.09 Million
-20,053 Reduced 35.12%
37,051 $1.84 Million
Q4 2020

Sep 21, 2023

BUY
$48.52 - $58.02 $910,380 - $1.09 Million
18,763 Added 48.94%
57,104 $2.85 Million
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $142,260 - $170,114
2,932 Added 5.41%
57,104 $2.86 Million
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $2.87 Million - $3.3 Million
54,055 Added 46200.85%
54,172 $2.97 Million
Q2 2020

Nov 02, 2020

BUY
$43.1 - $55.31 $5,042 - $6,471
117 New
117 $6,000
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $287,544 - $390,569
-7,609 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$42.46 - $50.46 $86,321 - $102,585
2,033 Added 36.46%
7,609 $379,000
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $223,709 - $253,540
5,576 New
5,576 $249,000
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $3.36 Million - $3.75 Million
-90,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $2.27 Million - $2.75 Million
63,958 Added 245.6%
90,000 $3.64 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $453,156 - $510,078
-12,294 Reduced 32.07%
26,042 $989,000
Q3 2018

Nov 14, 2018

BUY
$34.76 - $39.72 $1.14 Million - $1.3 Million
32,836 Added 597.02%
38,336 $1.52 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $2.24 Million - $2.4 Million
-64,835 Reduced 92.18%
5,500 $193,000
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $437,314 - $485,860
-13,264 Reduced 15.87%
70,335 $2.46 Million
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $2.68 Million - $2.91 Million
83,599
83,599 $2.9 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.